Ameriprise’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $2.66M | Sell |
|
|||||
|
2025
Q2 | $4.16M | Buy |
|
|||||
|
2025
Q1 | $1.44M | Sell |
|
|||||
|
2024
Q4 | $3.25M | Buy |
|
|||||
|
2024
Q3 | $2.56M | Sell |
|
|||||
|
2024
Q2 | $2.4M | Buy |
|
|||||
|
2024
Q1 | $1.36M | Sell |
|
|||||
|
2023
Q4 | $1.02M | Buy |
|
|||||
|
2023
Q3 | $993K | Buy |
|
|||||
|
2023
Q2 | $693K | Sell |
|
|||||
|
2023
Q1 | $1.04M | Sell |
|
|||||
|
2022
Q4 | $1.09M | Buy |
|
|||||
|
2022
Q3 | $592K | Sell |
|
|||||
|
2022
Q2 | $1.03M | Sell |
|
|||||
|
2022
Q1 | $1.66M | Buy |
|
|||||
|
2021
Q4 | $700K | Sell |
|
|||||
|
2021
Q3 | $933K | Sell |
|
|||||
|
2021
Q2 | $1.28M | Sell |
|
|||||
|
2021
Q1 | $2.67M | Sell |
|
|||||
|
2020
Q4 | $2.42M | Sell |
|
|||||
|
2020
Q3 | $4.83M | Buy |
|
|||||
|
2020
Q2 | $4.17M | Sell |
|
|||||
|
2020
Q1 | $5.32M | Sell |
|
|||||
|
2019
Q4 | $5.93M | Buy |
|
|||||
|
2019
Q3 | $2.08M | Buy |
|
|||||
|
2019
Q2 | $2.04M | Buy |
|
|||||
|
2019
Q1 | $2.5M | Sell |
|
|||||
|
2018
Q4 | $3.08M | Sell |
|
|||||
|
2018
Q3 | $5.01M | Buy |
|
|||||
|
2018
Q2 | $4.51M | Sell |
|
|||||
|
2018
Q1 | $3.32M | Buy |
|
|||||
|
2017
Q4 | $1.86M | Sell |
|
|||||
|
2017
Q3 | $25.6M | Sell |
|
|||||
|
2017
Q2 | $85.9M | Buy |
|
|||||
|
2017
Q1 | $41.3M | Buy |
|
|||||
|
2016
Q4 | $19.3M | Buy |
|
|||||
|
2016
Q3 | $23M | Buy |
|
|||||
|
2016
Q2 | $24.4M | Sell |
|
|||||
|
2016
Q1 | $148M | Buy |
|
|||||
|
2015
Q4 | $163M | Buy |
|
|||||
|
2015
Q3 | $127M | Sell |
|
|||||
|
2015
Q2 | $142M | Buy |
|
|||||
|
2015
Q1 | $130M | Buy |
|
|||||
|
2014
Q4 | $114M | Buy |
|
|||||
|
2014
Q3 | $96.4M | Sell |
|
|||||
|
2014
Q2 | $94.6M | Buy |
|
|||||
|
2014
Q1 | $86.9M | Sell |
|
|||||
|
2013
Q4 | $71.9M | Sell |
|
|||||
|
2013
Q3 | $70.9M | Buy |
|
|||||
|
2013
Q2 | $65M | Buy |
|